Lansing Street Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
1,793
+349
| +24% | +$272K | 0.42% | 43 |
|
|
2025
Q1 | $1.19M | Buy |
1,444
+132
| +10% | +$109K | 0.4% | 42 |
|
|
2024
Q4 | $1.01M | Buy |
1,312
+664
| +102% | +$513K | 0.35% | 44 |
|
|
2024
Q3 | $575K | Buy |
648
+21
| +3% | +$18.6K | 0.21% | 60 |
|
|
2024
Q2 | $568K | Buy |
627
+41
| +7% | +$37.1K | 0.24% | 61 |
|
|
2024
Q1 | $456K | Sell |
586
-29
| -5% | -$22.6K | 0.21% | 64 |
|
|
2023
Q4 | $358K | Buy |
+615
| New | +$358K | 0.19% | 62 |
|
|
2023
Q2 | $301K | Buy |
643
+1
| +0.2% | +$469 | 0.17% | 64 |
|
|
2023
Q1 | $220K | Buy |
642
+1
| +0.2% | +$343 | 0.14% | 75 |
|
|
2022
Q4 | $234K | Buy |
641
+8
| +1% | +$2.93K | 0.16% | 77 |
|
|
2022
Q3 | $205K | Hold |
633
| – | – | 0.16% | 78 |
|
|
2022
Q2 | $205K | Buy |
633
+1
| +0.2% | +$324 | 0.16% | 76 |
|
|
2022
Q1 | $197K | Buy |
+632
| New | +$197K | 0.13% | 81 |
|